Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices

Catheterization and Cardiovascular Interventions

Volumn 58, Issue 1, 2003, Pages 1-5

  Assali, Abid R ^a   Sdringola, Stefano ^a   Moustapha, Ali ^a   Ghani, Mohammad ^a   Salloum, Joseph ^a   Schroth, George ^a   Fujise, Ken ^a   Anderson, H Vernon ^a   Smalling, Richard W ^a   Rosales, Oscar R ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Medical Center Heart Consultants   (United States)

Author keywords

Femoral closure device; GP IIb IIIa inhibitors; Vascular access complication

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; SUTURE MATERIAL; TIROFIBAN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTERIOTOMY; ARTERIOVENOUS FISTULA; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL TRIAL; COMPRESSION; COMPRESSION THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; ELECTIVE SURGERY; EMERGENCY SURGERY; FALSE ANEURYSM; FEMALE; FEMORAL ARTERY; HEART INFARCTION; HEART SURGERY; HEMATOMA; HOMEOSTASIS; HUMAN; INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; RETROPERITONEAL HEMORRHAGE; RISK FACTOR; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS; VASCULAR ACCESS; VASCULAR SURGERY; WOUND CLOSURE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; CATHETERS, INDWELLING; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; EQUIPMENT FAILURE; FEMALE; FEMORAL ARTERY; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OUTCOME ASSESSMENT (HEALTH CARE); PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TIME FACTORS; TYROSINE; VASCULAR DISEASES;

EID: 0037219362     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10384     Document Type: Article

References (14)

1. Muller DM, Shamir KJ, Ellis SG, Topol EJ. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol 1992;69:63-68.
2. Popma JJ, Satler LF, Pilchard AD, Kent KM, Campbell A, Change YC, Clark C, Merit AJ, Butcher TA, Leon MB. Vascular complications after balloon and new device angioplasty. Circulation 1993;88:1569-1578.
3. EPILOG investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-1696.
4. Aguirre FV, Topol EJ, Ferguson JJ, Anderson K, Blankenship JC, Heuser RR, Sigmon K, Taylor M, Gottlieb R, Hanovich G, Rosenberg M, Donohue TJ, Weisman HF. Califf RM. for the EPIC investigators. Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. Circulation 1995;91:2882-2890.
5. Waksman R, King SB, Douglas JS, Shen Y, Ewing H, Mueller L, Ghazzal ZMB, Weintraub WS. Predictors of groin complications after balloon and new-device coronary intervention. Am J Cardiol 1995;75:886-889.
6. Omuigui NA, Califf RM, Pieper K, Keeler G, O'Hanesian A, Berdan LG, Mark DB, Talley JD, Topol EJ. Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-1). J Am Coll Cardiol 1995;26:922-930.
7. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-495.
8. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
9. Waksman R, King SB, Douglas JS, Shen Y, Ewing H, Mueller L, Ghazzal ZMB, Weintraub WS. Predictors of groin complications after balloon and new-device coronary intervention. Am J Cardiol 1995;75:886-889.
10. Silber S. Management of vascular sheath following PTCA. In: Ellis SG, Holmes DR Jr, editors. Strategic Approaches in Coronary Intervention, 2nd Ed. Philadelphia: Lippincott Williams and Wilkins; 2000. p 452-460.
11. Vatter JW, Ribeiro EE. The role of the Perclose system in patients with coronary intervention. In: Ellis SG, Holmes DR Jr, editors. Strategic Approaches in Coronary Intervention, 2nd Ed. Philadelphia: Lippincott Williams and Wilkins; 2000. p 460-470.
12. Cura FA, Kapadia SR, L'Allier PL, Schneider JP, Kreindel MS, Silver MJ, Yadav JS, Simpfendorfer CC, Raymond RR, Tuzcu EM, Franco I, Whitlow PL, Topol EJ, Ellis SG. Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade. Am J Cardiol 2000;86:780-782.
13. Morice MC, Lefevre T. Immediate post PTCA percutaneous suture of femoral arteries with the Perclose device: Results of high volume users. J Am Coll Cardiol 1998;31(Suppl A):101A.
14. Carey D, Martin JR, Moore CA, Valentine MC, Nygaard TW. Complications of femoral artery closure devices. Cathet Cardiovasc Intervent 2001;52:3-7.